OC
TMBR

Oppenheimer & Co’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Oppenheimer & Co’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2
Closed -$3K – 1411
2019
Q1 		$3K Hold
2
– – ﹤0.01% 1344
2018
Q4 		$3K Sell
2
-2
-50% -$4.74K ﹤0.01% 1237
2018
Q3 		$10K Buy
4
+2
+100% +$5.78K ﹤0.01% 1343
2018
Q2 		$8K Hold
2
– – ﹤0.01% 1322
2018
Q1 		$7K Buy
2
+1
+100% +$2.96K ﹤0.01% 1321
2017
Q4 		$2K Sell
1
-1
-50% -$2.73K ﹤0.01% 1311
2017
Q3 		$9K Hold
2
– – ﹤0.01% 1288
2017
Q2 		$13K Buy
+2
New +$17.4K ﹤0.01% 1291

Other funds holding TMBR

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFG
Nadler Financial Group Deerfield, Illinois $1.04B AUM 19.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Oppenheimer & Co's TMBR Position: Q2 2019 in Review

Oppenheimer & Co sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q2 2019, closing a stake of 2 shares — an estimated $3K sold.

Oppenheimer & Co first reported a position in TMBR in Q2 2017 and held it in 8 quarters. The position peaked at $13K in Q2 2017. 14 funds tracked by Wall St. Rank hold TMBR as of Q2 2019.

  • Oppenheimer & Co reported no remaining Timber Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Oppenheimer & Co sold 2 Timber Pharmaceuticals, Inc. shares in Q2 2019, an estimated $3K.
  • Oppenheimer & Co first reported a position in Timber Pharmaceuticals, Inc. in Q2 2017 and held it in 8 quarters.
  • Oppenheimer & Co's Timber Pharmaceuticals, Inc. position peaked at $13K in Q2 2017.
  • 14 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2019.

Based on Oppenheimer & Co's 13F filing for Q2 2019, filed 9 Aug 2019.